Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients.
- DOI
- 10.1016/j.clim.2025.110491
- Published
- 2025 Jul
- Container
- Clinical immunology (Orlando, Fla.)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.clim.2025.110491,
title = {Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients.},
author = {Antolí A and Gómez-Vázquez JL and Sierra-Fortuny A and Bermudez-Carre C and Framil M and Creus-Bachiller E and Viana-Errasti J and Rofes P and Rocamora-Blanch G and Hidalgo-Peña L and García-Serrano L and Rigo-Bonnin R and Feliubadaló L and Del Valle J and Calatayud L and Morandeira F and Lázaro C and Solanich X},
year = {2025},
journal = {Clinical immunology (Orlando, Fla.)},
doi = {10.1016/j.clim.2025.110491},
url = {https://doi.org/10.1016/j.clim.2025.110491}
}RIS
TY - JOUR TI - Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients. AU - Antolí A AU - Gómez-Vázquez JL AU - Sierra-Fortuny A AU - Bermudez-Carre C AU - Framil M AU - Creus-Bachiller E AU - Viana-Errasti J AU - Rofes P AU - Rocamora-Blanch G AU - Hidalgo-Peña L AU - García-Serrano L AU - Rigo-Bonnin R AU - Feliubadaló L AU - Del Valle J AU - Calatayud L AU - Morandeira F AU - Lázaro C AU - Solanich X PY - 2025 JO - Clinical immunology (Orlando, Fla.) DO - 10.1016/j.clim.2025.110491 UR - https://doi.org/10.1016/j.clim.2025.110491 ER -
APA
A, A., JL, G., A, S., C, B., M, F., E, C., J, V., P, R., G, R., L, H., L, G., R, R., L, F., J, D. V., L, C., F, M., C, L., & X, S. (2025). Autoantibodies neutralizing type I interferons remain a significant risk factor for critical COVID-19 pneumonia in vaccinated patients.. Clinical immunology (Orlando, Fla.). https://doi.org/10.1016/j.clim.2025.110491
Source records
- pubmed · retrieved 2026-09-27T14:38:15.418Z